Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ewelina Józefczuk"'
Autor:
Joanna Sulicka-Grodzicka, Piotr Szczepaniak, Ewelina Jozefczuk, Karol Urbanski, Mateusz Siedlinski, Łukasz Niewiara, Bartłomiej Guzik, Grzegorz Filip, Bogusław Kapelak, Karol Wierzbicki, Mariusz Korkosz, Tomasz J. Guzik, Tomasz P. Mikolajczyk
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundSystemic inflammation may cause endothelial activation, mediate local inflammation, and accelerate progression of atherosclerosis. We examined whether the levels of circulating inflammatory cytokines reflect local vascular inflammation and
Externí odkaz:
https://doaj.org/article/9bf6ced2b3e64c1a805ed49714dc23a6
Autor:
Jakub Baran, Łukasz Niewiara, Jakub Podolec, Mateusz Siedliński, Ewelina Józefczuk, Anna Bernacik, Rafał Badacz, Tadeusz Przewłocki, Piotr Pieniążek, Krzysztof Żmudka, Jacek Legutko, Anna Kabłak-Ziembicka
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 6, p 193 (2022)
Background: Although degenerative aortic valve stenosis (DAS) is the most prevalent growth-up congestive heart valve disease, still little known about relationships between DAS severity, vascular stiffness (VS), echocardiographic parameters, and seru
Externí odkaz:
https://doaj.org/article/602a19d65e674348aeb5a66744e9f5df
Publikováno v:
Kardiologia Polska. 81:221-231
Autor:
Jacek Stępniewski, Urszula Florczyk-Soluch, Witold Nowak, Monika Viscardi, Jozef Dulak, Ewelina Józefczuk, Mateusz Mendel, Alicja Jozkowicz, Karolina Bukowska-Strakova
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
Scientific Reports
Scientific Reports
Heme oxygenase-1 (HO-1; encoded by Hmox1), a downstream target of the Nrf2 transcription factor, has been postulated to be a negative regulator of osteoclasts (OCLs) differentiation. Here, we further explored such a hypothesis by examining HO-1 effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b561eed4ae6724522173695f89d7d84e
https://ruj.uj.edu.pl/xmlui/handle/item/56603
https://ruj.uj.edu.pl/xmlui/handle/item/56603
Autor:
Piotr Szczepaniak, Mateusz Siedlinski, Diana Hodorowicz-Zaniewska, Ryszard Nosalski, Tomasz P. Mikolajczyk, Aneta M. Dobosz, Anna Dikalova, Sergey Dikalov, Joanna Streb, Katarzyna Gara, Pawel Basta, Jaroslaw Krolczyk, Joanna Sulicka-Grodzicka, Ewelina Jozefczuk, Anna Dziewulska, Blessy Saju, Iwona Laksa, Wei Chen, John Dormer, Maciej Tomaszewski, Pasquale Maffia, Marta Czesnikiewicz-Guzik, Filippo Crea, Agnieszka Dobrzyn, Javid Moslehi, Tomasz Grodzicki, David G. Harrison, Tomasz J. Guzik
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 13 (2022)
Cardiovascular disease is the major cause of morbidity and mortality in breast cancer survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long-term vascular dysfunction caused by neoadjuvant chemotherapy (NACT) and
Externí odkaz:
https://doaj.org/article/4b3b8954d7104657a53492a95dc463f4